ArticlePharmacoEconomics - open2025

Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults.

Andrew H Briggs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.